CYTARABINE vs REVUFORJ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. CYTARABINE and REVUFORJ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CYTARABINE	REVUFORJ
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	CYTARABINE	REVUMENIB CITRATE
Manufacturer	Rising	Syndax
Dosage forms	Injectable	Tablet
Drug class	Nucleoside Metabolic Inhibitor	Menin Inhibitor
Boxed warning	None	Boxed warning
Treats	Leukemia, Lymphoma, Meningeal Neoplasms	Leukemia

cytarabine revuforj

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

CYTARABINE

REVUMENIB CITRATE

Manufacturer

Rising

Syndax

Dosage forms

Injectable

Tablet

Drug class

Nucleoside Metabolic Inhibitor

Menin Inhibitor

Boxed warning

None

Boxed warning

Treats

Leukemia, Lymphoma, Meningeal Neoplasms

Leukemia

Frequently asked questions

What is the difference between Cytarabine and Revuforj?

Cytarabine contains Cytarabine, while Revuforj contains Revumenib Citrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.